loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

World Biggest Tenders Source

This tender with title Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens. has been published on Bidding Source portal dated 18 Oct 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Contract notice
2019/S 201-487852
Germany
Germany-Hanover
18 Oct 2019
31 Dec 2021
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

128821- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany Awarded - 130186- Germany – Pharmaceutical products – Drug contracts awarded on 01.01.2026 and 01.07.2026 Germany 126159- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient nintedanib (ATC code: L01EX09). Germany 124866- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. Germany 124794- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (open-house procedure) Germany 120686- Germany – Pharmaceutical products – Conclusion of non-exclusive agreements for medicinal products containing the active ingredient relugolix (ATC code: L02BX04) by way of an open-house model Germany Awarded - 121069- Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Concizumab Germany Awarded - 120781- Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredients Eptacog beta and Willebrand factor Germany 122067- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient sultiam (WHO ATC code: N03AX03) Germany 122544- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient pegfilgrastim (WHO ATC code: L03AA13) Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans